European Medicines Agency reviewing safety of mixing Covid-19 vaccinations

The 'mix and match' vaccine process is being studied in three European countries. More data is expected to be submitted shortly for review. File picture

The European Medicines Agency (EMA) is reviewing mixing vaccine types to see if it is a safe and effective way to speed up vaccination rollouts.

This "mix and match" process is being studied in three European countries. More data is expected to be submitted shortly for review.